Prof. Dr. Ulrike Protzer took some time at the 2022 HBV Meeting to discuss the session she co-chaired on Preclinical Targets and therapies for chronic hepatitis B (CHB) and chronic hepatitis D (CHD). She also talks a little bit about her work in the field of hepatitis B research and what the future holds for hepatitis B (HBV) treatment.
Learn more about the International HBV meeting here: www.hbvmeeting...
Learn more about the Hepatitis B Foundation here: www.hepb.org/
22 окт 2024